{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:40:02Z","timestamp":1756316402605,"version":"3.44.0"},"reference-count":23,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,3]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Malignant mesotheliomas (MMs) are malignancies of the mesothelium, with primary deposits originating in the pleura, peritoneum, pericardium and the tunica vaginalis (ie, testicular). Metastatic spread is commonly reported to affect the liver, adrenal glands, kidney and contralateral lung (in cases of malignant pleural mesothelioma). Metastases to distant sites are uncommon. Spread to the oral cavity in particular is very rare. A total of 23 cases of metastatic spread to the oral cavity have been reported in the literature to date; of those, 9 cases have been to the tongue. Given the rarity of the site of metastasis, the management remains challenging. This case highlights a rare site of metastasis in MM, discusses treatment options available and briefly talks about technical limitations in treating a mobile structure such as the tongue. Good palliative and supportive care is crucial in managing cases where no curative treatment is possible.<\/jats:p>","DOI":"10.1136\/bcr-2020-241166","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T12:01:34Z","timestamp":1618228894000},"page":"e241166","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Tongue: the unusual site in malignant pleural mesothelioma"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0626-1426","authenticated-orcid":false,"given":"Iskandar Zulqarnain bin","family":"Mohamed","sequence":"first","affiliation":[{"name":"Department of Healthcare for Older People, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Idle","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Bates","sequence":"additional","affiliation":[{"name":"Department of Pathology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundus","family":"Yahya","sequence":"additional","affiliation":[{"name":"The Cancer Centre, Oncology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"2025082709581106000_14.4.e241166.1","first-page":"63-72","article-title":"Modern management of malignant pleural mesothelioma","volume":"7","author":"Patel","year":"2016","journal-title":"Lung Cancer"},{"key":"2025082709581106000_14.4.e241166.2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp307"},{"key":"2025082709581106000_14.4.e241166.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.05.001"},{"key":"2025082709581106000_14.4.e241166.4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/jdb7020007","article-title":"Mesothelium and malignant mesothelioma","volume":"7","author":"Hiriart","year":"2019","journal-title":"J Dev Biol"},{"key":"2025082709581106000_14.4.e241166.5","doi-asserted-by":"publisher","DOI":"10.1038\/ng.912"},{"key":"2025082709581106000_14.4.e241166.6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124327","article-title":"Inherited genetic mutations and polymorphisms in malignant mesothelioma: a comprehensive review","volume":"21","author":"Panou","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025082709581106000_14.4.e241166.7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","article-title":"Malignant mesothelioma and its non-asbestos causes","volume":"142","author":"Attanoos","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"2025082709581106000_14.4.e241166.8","first-page":"E35","article-title":"Bone metastases with nerve root compression as a late complication in patient with epithelial pleural mesothelioma","volume":"5","author":"Cedr\u00e9s","year":"2013","journal-title":"J Thorac Dis"},{"key":"2025082709581106000_14.4.e241166.9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hed.21942","article-title":"Metastases to the oral region from pleural mesothelioma: clinicopathologic review","volume":"35","author":"Sinon","year":"2013","journal-title":"Head Neck"},{"key":"2025082709581106000_14.4.e241166.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mco.2020.2131","article-title":"Malignant mesothelioma metastatic to the oral region and latest topics (review)","volume":"13","author":"Ohnishi","year":"2020","journal-title":"Mol Clin Oncol"},{"key":"2025082709581106000_14.4.e241166.11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amsu.2015.12.059","article-title":"Peritoneal mesothelioma metastasis to the tongue - Comparison with 8 pleural mesothelioma reports with tongue metastases","volume":"5","author":"Vazquez","year":"2016","journal-title":"Ann Med Surg"},{"key":"2025082709581106000_14.4.e241166.12","doi-asserted-by":"publisher","DOI":"10.1007\/s12199-007-0017-6"},{"key":"2025082709581106000_14.4.e241166.13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0985-4"},{"key":"2025082709581106000_14.4.e241166.14","unstructured":"Cancer Research UK . A trial looking at surgery for mesothelioma (MARS 2), 2020. Available: https:\/\/www.cancerresearchuk.org\/about-cancer\/find-a-clinical-trial\/a-trial-looking-at-surgery-for-mesothelioma-mars-2"},{"key":"2025082709581106000_14.4.e241166.15","unstructured":"US Department of Health and Human Services . Common terminology criteria for adverse events (CTCAE). 5 edn, 2017. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"},{"key":"2025082709581106000_14.4.e241166.16","unstructured":"Cancer Research UK . Mesothelioma survival statistics, 2020. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/mesothelioma\/survival [Accessed 11 Aug 2020]."},{"key":"2025082709581106000_14.4.e241166.17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01519","article-title":"Malignant pleural mesothelioma: state-of-the-art on current therapies and promises for the future","volume":"9","author":"Nicolini","year":"2019","journal-title":"Front Oncol"},{"key":"2025082709581106000_14.4.e241166.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"2025082709581106000_14.4.e241166.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6"},{"key":"2025082709581106000_14.4.e241166.20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01366","article-title":"The immune microenvironment in mesothelioma: mechanisms of resistance to immunotherapy","volume":"9","author":"Chu","year":"2019","journal-title":"Front Oncol"},{"key":"2025082709581106000_14.4.e241166.21","doi-asserted-by":"crossref","unstructured":"Baas P , Scherpereel A , Nowak A . First-line nivolumab + ipilimumab vs chemotherapy in unresectable malignant pleural mesothelioma: CheckMate 743. Presented at: International Association for the Study of Lung Cancer 2020 Presidential Symposium; 8 Aug, 2020.","DOI":"10.1016\/j.jtho.2020.08.004"},{"key":"2025082709581106000_14.4.e241166.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.150"},{"key":"2025082709581106000_14.4.e241166.23","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2017.03.96","article-title":"Malignant peritoneal mesothelioma: a review","volume":"5","author":"Kim","year":"2017","journal-title":"Ann Transl Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-241166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:58:19Z","timestamp":1756313899000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-241166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,12]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-241166"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-241166","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}